(Reuters) -Telehealth company Mangoceuticals said on Thursday it has partnered with Eli Lilly and Novo Nordisk to sell the ...

Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc , ...

While Mangoceuticals has no direct contractual relationship with Eli Lilly or Novo Nordisk, through MangoRx Direct and Peaches RX Direct, which, as mentioned above, have been thoroughly vetted and ...

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies ...

Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and ...

Investing.com -- Mangoceuticals Inc (NASDAQ:MGRX) stock plunged 17% Thursday after pharmaceutical giants Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) denied having partnerships with the telehealth ...

Mangoceuticals (MGRX) stock climbs as the company partners with Eli Lilly (LLY) and Novo Nordisk (NVO) to offer GLP-1 weight ...

Mangoceuticals (NASDAQ:MGRX – Get Free Report) is one of 18 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it weigh in compared to ...

Mangoceuticals (NASDAQ:MGRX – Get Free Report) is one of 19 public companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it contrast to its peers?

The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s ...